Citations (28)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Massimo Martino, Marco Rossi, Anna Ferreri, Barbara Loteta, Antonella Morabito, Tiziana Moscato, Giuseppe Console, Vanessa Innao, Virginia Naso, Pasquale Fabio Provenzano, Anna Grazia Recchia & Massimo Gentile. (2019) Quality of life outcomes in multiple myeloma patients: a summary of recent clinical trials. Expert Review of Hematology 12:8, pages 665-684.
Read now
Read now
Uri Rozovski, Ella Naparstek, Shani Frank, Alexey Fourman, Eti Zigman-Hoffman, Margalit Bleiberg, Moshe Yeshurun, Svetlana Trestman & Boris Tartakovsky. (2019) Impaired lymphocyte reconstitution after autologous transplant is associated with apoptosis of CD8+ T cells and adverse clinical outcome. Leukemia & Lymphoma 60:9, pages 2264-2270.
Read now
Read now
Articles from other publishers (26)
Meera Mohan, Siegfried Janz, Ruta Brazauskas, Michael B. Dwinell, Bi Qing Teng, Grant Yun, Jing Dong, Marcelo C. Pasquini, Sergio Giralt, Heather Landau, Edward Stadtmauer, Amrita Krishnan & Anita D’Souza. (2023) Increased CXCL10 is seen at 1-year after autologous hematopoietic cell transplantation in multiple myeloma patients on maintenance lenalidomide therapy. Bone Marrow Transplantation 58:8, pages 953-955.
Crossref
Crossref
Ashley M. Nelson, Alexandra A. Erdmann, Christopher L. Coe, Mark B. Juckett, Keayra Morris, Jennifer M. Knight, Peiman Hematti & Erin S. Costanzo. (2023) Inflammatory cytokines and depression symptoms following hematopoietic cell transplantation. Brain, Behavior, and Immunity 112, pages 11-17.
Crossref
Crossref
Xin Shelley Wang, Samer A. Srour, Tito Mendoza, Meagan Whisenant, Ishwaria Subbiah, Elizabeth Gonzalez, Mona Kamal, Shu‐En Shen, Charles Cleeland, Partow Kebriaei, Katayoun Rezvani, Sattva Neelapu, Sairah Ahmed & Elizabeth Shpall. (2023) Development and validation of a patient‐reported outcome measure to assess symptom burden after chimeric antigen receptor T‐cell therapy. British Journal of Haematology 201:4, pages 738-746.
Crossref
Crossref
Orla McCourt, Abigail Fisher, Joanne Land, Gita Ramdharry, Anna L Roberts, Georgios Bekris & Kwee Yong. (2023) “What I wanted to do was build myself back up and prepare”: qualitative findings from the PERCEPT trial of prehabilitation during autologous stem cell transplantation in myeloma. BMC Cancer 23:1.
Crossref
Crossref
Xin Shelley Wang, Samer A. Srour, Meagan Whisenant, Ishwaria M. Subbiah, Tsun Hsuan Chen, Darcy Ponce, Araceli Garcia Gonzalez, Mona Kamal, Tito Mendoza, Charles S. Cleland, Partow Kebriaei, Sattva S. Neelapu, Katayoun Rezvani, Sairah Ahmed & Elizabeth Shpall. (2021) Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic Malignancies. Transplantation and Cellular Therapy 27:11, pages 930.e1-930.e10.
Crossref
Crossref
Julie G. Walker, Terri S. Armstrong, Barbara J. O'Brien, Mark R. Gilbert, Rebecca L. Casarez, Christopher Fagundes, Cobi J. Heijnen, Clark R. Andersen, Ying Yuan, Jimin Wu & Geri LoBiondo-Wood. (2021) Associations of meaning of illness with psychosocial, clinical, and immunological characteristics in patients with Leptomeningeal metastasis. Comprehensive Psychoneuroendocrinology 8, pages 100099.
Crossref
Crossref
Xin Shelley Wang, Qiuling Shi, Tito R. Mendoza, Araceli Garcia-Gonzalez, Ting-Yu Chen, Mona Kamal, Tsun Hsuan Chen, Cobi Heijnen, Robert Z. Orlowski & Charles S. Cleeland. (2021) Minocycline for symptom reduction in patients with multiple myeloma during maintenance therapy: a phase II placebo-controlled randomized trial. Supportive Care in Cancer 29:10, pages 6099-6107.
Crossref
Crossref
Mohammed S. Ebraheem, Hsien Seow, Amaris K. Balitsky, Gregory R. Pond, Tanya M. Wildes, Branavan Sivapathasundaram, Jonathan Sussman & Hira Mian. (2021) Trajectory of Symptoms in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma: A Population-Based Cohort Study of Patient-Reported Outcomes. Clinical Lymphoma Myeloma and Leukemia 21:9, pages e714-e721.
Crossref
Crossref
Dominika Bębnowska, Rafał Hrynkiewicz, Ewelina Grywalska, Marcin Pasiarski, Barbara Sosnowska-Pasiarska, Iwona Smarz-Widelska, Stanisław Góźdź, Jacek Roliński & Paulina Niedźwiedzka-Rystwej. (2021) Immunological Prognostic Factors in Multiple Myeloma. International Journal of Molecular Sciences 22:7, pages 3587.
Crossref
Crossref
Dickran Kazandjian, Clifton C. Mo, Ola Landgren & Paul G. Richardson. (2020) The role of high‐dose melphalan with autologous stem‐cell transplant in multiple myeloma: is it time for a paradigm shift?. British Journal of Haematology 191:5, pages 692-703.
Crossref
Crossref
Tito R. Mendoza. 2020. Immunotherapy. Immunotherapy
335
339
.
Christina Ramsenthaler, Wei Gao, Richard J Siegert, Polly M Edmonds, Stephen A Schey & Irene J Higginson. (2019) Symptoms and anxiety predict declining health-related quality of life in multiple myeloma: A prospective, multi-centre longitudinal study. Palliative Medicine 33:5, pages 541-551.
Crossref
Crossref
Geraldine Walpole, Helen Clark & Maura Dowling. (2018) Myeloma patients' experiences of haematopoietic stem cell transplant: A qualitative thematic synthesis. European Journal of Oncology Nursing 35, pages 15-21.
Crossref
Crossref
Letícia Navarro Gordan Ferreira Martins, Andrea Akemi Morita, Geise Ellen Broto, Érika Takakura, Suelen Santos da Silva, Fernanda Tomiotto-Pellissier, Ivete Conchon-Costa, Wander Rogério Pavanelli, Carolina Panis & Décio Sabbatini Barbosa. (2018) Interferon-gamma in mobilized stem cells: A possible prognostic marker in early post-transplant management in multiple myeloma. Cytokine 108, pages 127-135.
Crossref
Crossref
Rajshekhar Chakraborty, Betty K. Hamilton, Shahrukh K. Hashmi, Shaji K. Kumar & Navneet S. Majhail. (2018) Health-Related Quality of Life after Autologous Stem Cell Transplantation for Multiple Myeloma. Biology of Blood and Marrow Transplantation 24:8, pages 1546-1553.
Crossref
Crossref
Alessandro Allegra, Vanessa Innao, Demetrio Gerace, Andrea Gaetano Allegra, Doriana Vaddinelli, Oriana Bianco & Caterina Musolino. (2018) The adipose organ and multiple myeloma: Impact of adipokines on tumor growth and potential sites for therapeutic intervention. European Journal of Internal Medicine 53, pages 12-20.
Crossref
Crossref
Bethany Andrews Rhoten, Barbara A. Murphy, Mary S. Dietrich & Sheila Hedden Ridner. (2018) Depressive symptoms, social anxiety, and perceived neck function in patients with head and neck cancer. Head & Neck 40:7, pages 1443-1452.
Crossref
Crossref
Xinhua Qu, Jingtian Mei, Zhifeng Yu, Zanjing Zhai, Han Qiao & Kerong Dai. (2018) Lenalidomide regulates osteocytes fate and related osteoclastogenesis via IL-1β/NF-κB/RANKL signaling. Biochemical and Biophysical Research Communications 501:2, pages 547-555.
Crossref
Crossref
Nina Shah, Qiuling Shi, Sergio Giralt, Loretta Williams, Qaiser Bashir, Muzaffar Qazilbash, Richard E. Champlin, Charles S. Cleeland & Xin Shelley Wang. (2017) Utility of a patient-reported outcome in measuring functional impairment during autologous stem cell transplant in patients with multiple myeloma. Quality of Life Research 27:4, pages 979-985.
Crossref
Crossref
Cyrille Hulin, Timon Hansen, Louise Heron, Rachel Pughe, Matthew Streetly, Ananda Plate, Sue Perkins, Kate Morgan, Antoine Tinel, Filipe Rodrigues & Karthik Ramasamy. (2017) Living with the burden of relapse in multiple myeloma from the patient and physician perspective. Leukemia Research 59, pages 75-84.
Crossref
Crossref
P Roy, T Mukherjee, B Chatterjee, B Vijayaragavan, B Banoth & S Basak. (2016) Non-canonical NFκB mutations reinforce pro-survival TNF response in multiple myeloma through an autoregulatory RelB:p50 NFκB pathway. Oncogene 36:10, pages 1417-1429.
Crossref
Crossref
Caterina Musolino, Alessandro Allegra, Vanessa Innao, Andrea Gaetano Allegra, Giovanni Pioggia & Sebastiano Gangemi. (2017) Inflammatory and Anti-Inflammatory Equilibrium, Proliferative and Antiproliferative Balance: The Role of Cytokines in Multiple Myeloma. Mediators of Inflammation 2017, pages 1-24.
Crossref
Crossref
Christina Ramsenthaler, Thomas R. Osborne, Wei Gao, Richard J. Siegert, Polly M. Edmonds, Stephen A. Schey & Irene J. Higginson. (2016) The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study. BMC Cancer 16:1.
Crossref
Crossref
Qiuling Shi, Tito R. Mendoza, Xin Shelley Wang & Charles S. Cleeland. (2016) Using a symptom-specific instrument to measure patient-reported daily functioning in patients with cancer. European Journal of Cancer 67, pages 83-90.
Crossref
Crossref
Shaofeng Wang & Wenhua Liu. (2016) Paeoniflorin inhibits proliferation and promotes apoptosis of multiple myeloma cells via its effects on microRNA-29b and matrix metalloproteinase-2. Molecular Medicine Reports 14:3, pages 2143-2149.
Crossref
Crossref
Ranjit Kumar Chaudhary, Vijaya Raj Bhatt & Julie M. Vose. (2015) Management of Extranodal Natural Killer/T-Cell Lymphoma, Nasal Type. Clinical Lymphoma Myeloma and Leukemia 15:5, pages 245-252.
Crossref
Crossref